Clinical management of borderline tumours of the ovary: Results of a multicentre survey of 323 clinics in Germany

British Journal of Cancer

Volumn 100, Issue 11, 2009, Pages 1731-1738

  Coumbos, A ^a   Sehouli, J ^b   Chekerov, R ^b   Schaedel, D ^c   Oskay Oezcelik, G ^b   Lichtenegger, W ^b   Kuehn, W ^b  

^a Outpatient Practice of Gynecological Oncology   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c Laser und Medizin Technologie GmbH   (Germany)

Author keywords

Borderline ovarian tumour; Clinical management; Diagnosis; Multicentre survey; Therapy

Indexed keywords

CA 125 ANTIGEN; CARBOPLATIN; CISPLATIN; TAXANE DERIVATIVE;

ARTICLE; BORDERLINE OVARY TUMOR; CANCER CHEMOTHERAPY; CANCER SURGERY; COMPUTER ASSISTED TOMOGRAPHY; GERMANY; HIGH RISK PATIENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY TUMOR; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY; STRUCTURED QUESTIONNAIRE; TRANSVAGINAL ECHOGRAPHY;

ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; FEMALE; GERMANY; HOSPITALIZATION; HOSPITALS; HUMANS; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROGNOSIS; QUESTIONNAIRES; RISK FACTORS;

EID: 67349243619     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605065     Document Type: Article

References (43)

1. Boran N, Cil AP, Tulunay G, Ozturkoglu E, Koc S, Bulbul D, Kose MF (2005) Fertility and recurrence results of conservative surgery for borderline ovarian tumors. Gynecol Oncol 97: 845-851
2. Cadron I, Leunen K, van Gorp T, Amant F, Neven P, Vergote I (2007) Management of borderline ovarian neoplasms. J Clin Oncol 25: 2928-2937
3. Chang SJ, Ryu HS, Chang KH, Yoo SC, Yoon JH (2008) Prognostic significance of the micropapillary pattern in patients with serous borderline ovarian tumors. Acta Obstet Gynecol Scand 87: 476-481
4. Cohen L, Fishman DA (2002) Ultrasound and ovarian cancer. Cancer Treat Res 107: 119-132
5. Cusido M, Balaguero L, Hernandez G, Falcon O, Rodriguez-Escudero FJ, Vargas JA, Vidart JA, Zamora L, Monera M, Alonso A (2007) Results of the national survey of borderline ovarian tumors in Spain. Gynecol Oncol 104: 617-622
6. Denkert C, Dietel M (2005) Borderline tumors of the ovary and peritoneal implants. Verh Dtsch Ges Pathol 89: 84-91
7. Du Bois A, Pfisterer J, Kellermann L, Kreienberg R (2001) Treatment of advanced ovarian cancer in Germany: the impact of participation in clinical trials. Geburtsh Frauenheilk 61: 863-871
8. Du Bois A, Rochon J, Lamparter C, Pfisterer J (2005) Pattern of care and impact of participation in clinical studies on the outcome in ovarian cancer. Int J Gynecol Cancer 15: 183-191
9. Fauvet R, Boccara J, Dufournet C, David-Montefiore E, Poncelet C, Darai E (2004) Restaging surgery for women with borderline ovarian tumors: results of a French multicenter study. Cancer 100: 1145-1151
10. Gershenson DM, Silva EG, Levy L, Burke TW, Wolf JK, Tornos C (1998a) Ovarian serous borderline tumors with invasive peritoneal implants. Cancer 82: 1096-1103
11. Gershenson DM, Silva EG, Tortolero-Luna G, Levenback C, Morris M, Tornos C (1998b) Serous borderline tumors of the ovary with noninvasive peritoneal implants. Cancer 83: 2157-2163
12. Gotlieb WH, Chetrit A, Menczer J, Hirsh-Yechezkel G, Lubin F, Friedman E, Modan B, Ben-Baruch G (2005) Demographic and genetic characteristics of patients with borderline ovarian tumors as compared to early stage invasive ovarian cancer. Gynecol Oncol 97: 780-783
13. Hart WR (2005) Borderline epithelial tumors of the ovary. Mod Pathol 18: S33-S50
14. Jones MB (2006) Borderline ovarian tumors: current concepts for prognostic factors and clinical management. Clin Obstet Gynecol 49: 517-525
15. Kumpulainen S, Kuoppala T, Leminen A, Komulainen M, Puistola U, Sankila R, Makinen J, Grenman S (2007) Surgical staging, treatment, and follow-up of borderline tumors in different hospital categories: a prospective nationwide survey in Finland. Acta Obstet Gynecol Scand 86: 610-614
16. Kurman RJ, Visvanathan K, Roden R, Wu TC, Shih IeM (2008) Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis. Am J Obstet Gynecol 198(4): 351-356
17. Lichtenegger W, Sehouli J, Buchmann E, Karajanev C, Weidemann H (1998) Operative results after primary and secondary debulking-operations in advanced ovarian cancer (AOC). J Obstet Gynaecol Res 24: 447-451
18. Longacre TA, McKenney JK, Tazelaar HD, Kempson RL, Hendrickson MR (2005) Ovarian serous tumors of low malignant potential (borderline tumors): outcome-based study of 276 patients with long-term (> or = 5-year) follow-up. Am J Surg Pathol 29: 707-723
19. Maltaris T, Koelbl H, Seufert R, Kiesewetter F, Beckmann MW, Mueller A, Dittrich R (2006) Gonadal damage and options for fertility preservation in female and male cancer survivors. Asian J Androl 8: 515-533
20. Marcickiewicz J, Brannstrom M (2006) Fertility preserving surgical treatment of borderline ovarian tumour: long-term consequence for fertility and recurrence. Acta Obstet Gynecol Scand 85: 1496-1500
21. Meinhold-Heerlein I, Bauerschlag D, Hilpert F, Dimitrov P, Sapinoso LM, Orlowska-Volk M, Bauknecht T, Park TW, Jonat W, Jacobsen A, Sehouli J, Luttges J, Krajewski M, Krajewski S, Reed JC, Arnold N, Hampton GM (2005) Molecular and prognostic distinction between serous ovarian carcinomas of varying grade and malignant potential. Oncogene 24: 1053-1065
22. Poncelet C, Fauvet R, Boccara J, Darai E (2006) Recurrence after cystectomy for borderline ovarian tumors: results of a French multicenter study. Ann Surg Oncol 13: 565-571
23. Reles A, Wein U, Lichtenegger W (1997) Transvaginal color Doppler sonography and conventional sonography in the preoperative assessment of adnexal masses. J Clin Ultrasound 25: 217-225
24. Rollins SE, Young RH, Bell DA (2006) Autoimplants in serous borderline tumors of the ovary: a clinicopathologic study of 30 cases of a process to be distinguished from serous adenocarcinoma. Am J Surg Pathol 30: 457-462
25. Romagnolo C, Gadducci A, Sartori E, Zola P, Maggino T (2006) Management of borderline ovarian tumors: results of an Italian multicenter study. Gynecol Oncol 101: 255-260
26. Schem C, Bauerschlag DO, Meinhold-Heerlein I, Fischer D, Friedrich M, Maass N (2007) Benign and borderline tumors of the ovary. Ther Umsch 64: 369-374
27. Schmalfeldt B, Pfisterer J (2007) Interdisziplinäre S2k-Leitlinie für die Diagnostik und Therapie maligner Ovarialtumoren. Zuckschwerdt Verlag: 1. Auflage, ed. K.O.d.A.G.O. e.V
28. Sehouli J, Denkert C, Dietl M, Lichtenegger W (2005a) Management von Borderlinetumoren des Ovars (BOT) [Management of borderline ovarian tumours]. Onkologe 11: 1127-1138
29. Sehouli J, Kostromitskaia J, Stengel D, du Bois A (2005b) Why institutions do not participate in ovarian cancer trials - results from a survey in Germany. Onkologie 28: 13-17
30. Seidman JD, Sherman ME, Kurman RJ (1998) Recurrent serous borderline tumors of the ovary. Int J Gynecol Pathol 17: 387-389
31. Seidman JD, Soslow RA, Vang R, Berman JJ, Stoler MH, Sherman ME, Oliva E, Kajdacsy-Balla A, Berman DM, Copeland LJ (2004) Borderline ovarian tumors: diverse contemporary viewpoints on terminology and diagnostic criteria with illustrative images. Hum Pathol 35: 918-933
32. Sherman ME, Berman J, Birrer MJ, Cho KR, Ellenson LH, Gorstein F, Seidman JD (2004) Current challenges and opportunities for research on borderline ovarian tumors. Hum Pathol 35: 961-970
33. Shiraki M, Otis CN, Donovan JT, Powell JL (1992) Ovarian serous borderline epithelial tumors with multiple retroperitoneal nodal involvement. Gynecol Oncol 46: 255-258
34. Silva EG, Gershenson DM, Malpica A, Deavers M (2006) The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent. Am J Surg Pathol 30: 1367-1371
35. Skirnisdottir I, Garmo H, Wilander E, Holmberg L (2008) Borderline ovarian tumors in Sweden 1960-2005: trends in incidence and age at diagnosis compared to ovarian cancer. Int J Cancer 123: 1897-1901
36. Suh-Burgmann E (2006) Long-term outcomes following conservative surgery for borderline tumor of the ovary: a large population-based study. Gynecol Oncol 103: 841-847
37. Sutton GP, Bundy BN, Omura GA, Yordan EL, Beecham JB, Bonfiglio T (1991) Stage III ovarian tumors of low malignant potential treated with cisplatin combination therapy (a Gynecologic Oncology Group study). Gynecol Oncol 41: 230-233
38. Tinelli R, Tinelli A, Tinelli FG, Cicinelli E, Malvasi A (2006) Conservative surgery for borderline ovarian tumors: a review. Gynecol Oncol 100: 185-191
39. Togashi K (2003) Ovarian cancer: the clinical role of US, CT, and MRI. Eur Radiol 13: L87-L104
40. Trope CG, Kristensen G, Makar A (2000) Surgery for borderline tumor of the ovary. Semin Surg Oncol 19: 69-75
41. Wong HF, Low JJ, Chua Y, Busmanis I, Tay EH, Ho TH (2007) Ovarian tumors of borderline malignancy: a review of 247 patients from 1991 to 2004. Int J Gynecol Cancer 17: 342-349
42. Yinon Y, Beiner ME, Gotlieb WH, Korach Y, Perri T, Ben-Baruch G (2007) Clinical outcome of cystectomy compared with unilateral salpingo-oophorectomy as fertility-sparing treatment of borderline ovarian tumors. Fertil Steril 88: 479-484
43. Yokoyama Y, Moriya T, Takano T, Shoji T, Takahashi O, Nakahara K, Yamada H, Yaegashi N, Okamura K, Izutsu T, Sugiyama T, Tanaka T, Kurachi H, Sato A, Tase T, Mizunuma H (2006) Clinical outcome and risk factors for recurrence in borderline ovarian tumours. Br J Cancer 94: 1586-1591